FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martin Widschwendter

Research Profile

Physiology

Disorders

Chemicals & Drugs

Anatomy

Tumor Cells, Cultured

Procedures

Case Control Studies

Concepts & Ideas

Co-author Network

Publications

TOP 3
Martin Widschwendter; Allison Jones; Andrew E Teschendorff
Epigenetics makes its mark on women-specific cancers--an opportunity to redefine oncological approaches?
Nyaladzi Balogun; Alastair Forbes; Martin Widschwendter; Anne Lanceley
Noninvasive nutritional management of ovarian cancer patients: beyond intestinal obstruction.
E O Fourkala; A Gentry-Maharaj; I Jacobs; R Manchanda; M Burnell; Anne Dawnay; A Ryan; Martin Widschwendter; Usha Menon
Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martin Widschwendter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Martin Widschwendter; Allison Jones; Andrew E Teschendorff
Epigenetics makes its mark on women-specific cancers--an opportunity to redefine oncological approaches?
Gynecologic oncology 2013;128(1):134-43.
2012: Nyaladzi Balogun; Alastair Forbes; Martin Widschwendter; Anne Lanceley
Noninvasive nutritional management of ovarian cancer patients: beyond intestinal obstruction.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2012;22(6):1089-95.
2012: E O Fourkala; A Gentry-Maharaj; I Jacobs; R Manchanda; M Burnell; Anne Dawnay; A Ryan; Martin Widschwendter; Usha Menon
Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening.
British journal of cancer 2012;106(12):1910-6.
2012: Andrew E Teschendorff; Martin Widschwendter
Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions.
Bioinformatics (Oxford, England) 2012;28(11):1487-94.
2012: Evangelia-Ourania Fourkala; Aleksandra Gentry-Maharaj; Richard Gunu; Guido Hasenbrink; Ian Jacobs; Hella Lichtenberg-Fraté; Matthew Burnell; Anne Dawnay; Jeremy Ford; Christina Soromani; Martin Widschwendter; Alexey Zaikin; Usha Menon
Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.
Endocrine-related cancer 2012;19(2):137-47.
2012: Vasco Liberal; Hanna-Stina Martinsson-Ahlzén; Clare H McGowan; Charles H. Spruck; Martin Widschwendter; Jennifer Liberal; Steven I Reed
Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(8):2754-9.
2012: Joanna Zhuang; Michal Zikan; David Cibula; Heidi Fiegl; Ian J Jacobs; Allison Jones; Henry C Kitchener; Shih-Han Lee; Esther Ng; Helga B Salvesen; Alexandra Sargent; Andrew E Teschendorff; Martin Widschwendter
The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer.
PLoS genetics 2012;8(2):e1002517.
2012: Joanna Zhuang; Martin Widschwendter; Andrew E Teschendorff
A comparison of feature selection and classification methods in DNA methylation studies using the Illumina Infinium platform.
BMC bioinformatics 2012;13():59.
2012: Andrew E Teschendorff; Joanna J Zhuang; Heidi Fiegl; Allison Jones; Henry C Kitchener; Alexandra Sargent; Martin Widschwendter
Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation.
Genome medicine 2012;4(3):24.
2011: Andrew E Teschendorff; Joanna Zhuang; Martin Widschwendter
Independent surrogate variable analysis to deconvolve confounding factors in large-scale microarray profiling studies.
Bioinformatics (Oxford, England) 2011;27(11):1496-505.
2011: Nyaladzi Balogun; Aleksandra Gentry-Maharaj; Eva L Wozniak; Anita Lim; Andy Ryan; Susan J Ramus; Jeremy Ford; Matthew Burnell; Martin Widschwendter; Sue F Gessler; Simon A Gayther; Ian J Jacobs; Usha Menon
Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking study.
Journal of clinical epidemiology 2011;64(5):525-30.
2010: Christina Thirlwell; Marianne Eymard; Andrew Feber; Andrew E Teschendorff; Kerra Pearce; Matthias Lechner; Martin Widschwendter; Stephan Beck
Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip.
Methods (San Diego, Calif.) 2010;52(3):248-54.
2010: Andrew E Teschendorff; Usha Menon; Aleksandra Gentry-Maharaj; Susan J Ramus; Daniel J Weisenberger; Hui Shen; Mihaela Campan; Houtan Noushmehr; Christopher G Bell; A Peter Maxwell; David A Savage; Elisabeth Mueller-Holzner; Christian Marth; Gabrijela Kocjan; Simon A Gayther; Allison Jones; Stephan Beck; Wolfgang Wagner; Peter W Laird; Ian J Jacobs; Martin Widschwendter
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer.
Genome research 2010;20(4):440-6.
2010: Regina Berger; Heidi Fiegl; Georg Goebel; Petra Obexer; Michael J Ausserlechner; Wolfgang Doppler; Cornelia Hauser-Kronberger; Roland Reitsamer; Daniel Egle; Daniel Reimer; Elisabeth Müller-Holzner; Allison Jones; Martin Widschwendter
Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors.
Cancer science 2010;101(4):1059-66.
2010: Evangelia-Ourania Fourkala; Cornelia Hauser-Kronberger; Sophia Apostolidou; Matthew Burnell; Allison Jones; Johannes Grall; Roland Reitsamer; Heidi Fiegl; Ian Jacobs; Usha Menon; Martin Widschwendter
DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery.
Breast cancer research and treatment 2010;120(2):345-55.
2010: Allison Jones; Rebecca Kristeleit; Matthias Lechner; Evangelia-Ourania Fourkala; Martin Widschwendter
Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers.
Epigenomics 2010;2(1):9-38.
2009: Sophia Apostolidou; Richard Hadwin; Matthew Burnell; Allison Jones; Donna Baff; Nitisha Pyndiah; Tim Mould; Ian J Jacobs; Simon Beddows; Gabrijela Kocjan; Martin Widschwendter
DNA methylation analysis in liquid-based cytology for cervical cancer screening.
International journal of cancer. Journal international du cancer 2009;125(12):2995-3002.
2009: Martin Widschwendter; Sophia Apostolidou; Allison A Jones; Evangelia O Fourkala; Rupali Arora; Celeste L Pearce; Melissa A Frasco; Ayse Ayhan; Michal Zikan; David Cibula; Cem A Iyibozkurt; Ekrem Yavuz; Cornelia Hauser-Kronberger; Louis Dubeau; Usha Menon; Ian J Jacobs
HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: a proof of principle study.
International journal of cancer. Journal international du cancer 2009;125(9):2214-8.
2009: Martin Widschwendter; H Lichtenberg-Frate; G Hasenbrink; S Schwarzer; Anne Dawnay; A Lam; Usha Menon; S Apostolidou; E Raum; C Stegmaier; Ian J Jacobs; H Brenner
Serum oestrogen receptor alpha and beta bioactivity are independently associated with breast cancer: a proof of principle study.
British journal of cancer 2009;101(1):160-5.
2009: Andrew E Teschendorff; Usha Menon; Aleksandra Gentry-Maharaj; Susan J Ramus; Simon A Gayther; Sophia Apostolidou; Allison Jones; Matthias Lechner; Stephan Beck; Ian J Jacobs; Martin Widschwendter
An epigenetic signature in peripheral blood predicts active ovarian cancer.
PloS one 2009;4(12):e8274.
2008: Heidi Fiegl; Gudrun Windbichler; Elisabeth Mueller-Holzner; Georg Goebel; Matthias Lechner; Ian J Jacobs; Martin Widschwendter
HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancer.
International journal of cancer. Journal international du cancer 2008;123(3):725-9.
2008: Heidi Fiegl; Allison Jones; Cornelia Hauser-Kronberger; Georg Hutarew; Roland Reitsamer; Robin L Jones; Mitch Dowsett; Elisabeth Mueller-Holzner; Gudrun Windbichler; Guenter Daxenbichler; Georg Goebel; Christian Ensinger; Ian Jacobs; Martin Widschwendter
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3494-502.
2008: Martin Widschwendter; Sophia Apostolidou; Elke Raum; Dietrich Rothenbacher; Heidi Fiegl; Usha Menon; Christa Stegmaier; Ian J Jacobs; Hermann Brenner
Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study.
PloS one 2008;3(7):e2656.
2007: Shahab Akhoondi; Dahui Sun; Natalie von der Lehr; Sophia Apostolidou; Kathleen Klotz; Alena Maljukova; Diana Cepeda; Heidi Fiegl; Dimitra Dafou; Dimitra Dofou; Christian Marth; Elisabeth Mueller-Holzner; Martin Corcoran; Markus Dagnell; Sepideh Zabihi Nejad; Babak Noori Nayer; Mohammad Reza Zali; Johan Hansson; Suzanne Egyhazi; Fredrik Petersson; Per Sangfelt; Hans Nordgren; Dan Grander; Steven I Reed; Martin Widschwendter; Olle Sangfelt; Charles H. Spruck
FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Cancer research 2007;67(19):9006-12.
2007: Martin Widschwendter; Heidi Fiegl; Daniel Egle; Elisabeth Mueller-Holzner; Gilbert Spizzo; Christian Marth; Daniel J Weisenberger; Mihaela Campan; Joanne Young; Ian Jacobs; Peter W Laird
Epigenetic stem cell signature in cancer.
Nature genetics 2007;39(2):157-8.
2006: Martin Widschwendter; Usha Menon
Circulating methylated DNA: a new generation of tumor markers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7205-8.
2006: Charles H. Spruck; Dahui Sun; Heidi Fiegl; Christian Marth; Elisabeth Mueller-Holzner; Georg Goebel; Martin Widschwendter; Steven I Reed
Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer.
Cancer research 2006;66(14):7355-60.
2006: Daniel J Weisenberger; Kimberly D Siegmund; Mihaela Campan; Joanne Young; Tiffany I Long; Mark A Faasse; Gyeong Hoon Kang; Martin Widschwendter; Deborah Weener; Daniel Buchanan; Hoey Koh; Lisa A Simms; Melissa Barker; Barbara A Leggett; Joan Levine; Myungjin Kim; Amy J French; Stephen N Thibodeau; Jeremy Jass; Robert W Haile; Peter W Laird
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer.
Nature genetics 2006;38(7):787-93.
2006: Heidi Fiegl; Simone Millinger; Georg Goebel; Elisabeth Müller-Holzner; Christian Marth; Peter W Laird; Martin Widschwendter
Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer.
Cancer research 2006;66(1):29-33.
2005: Heidi Fiegl; Simone Millinger; Elisabeth Mueller-Holzner; Christian Marth; Christian Ensinger; Andreas Berger; Helmut Klocker; Georg Goebel; Martin Widschwendter
Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients.
Cancer research 2005;65(4):1141-5.
2005: Georg Goebel; Hannes M Müller; Heidi Fiegl; Martin Widschwendter
Gene methylation data--a new challenge for bioinformaticians?
Methods of information in medicine 2005;44(4):516-9.
2004: Kesmic Jackson; Mimi C Yu; Kazuko Arakawa; Emerich Fiala; Byungwoo Youn; Heidi Fiegl; Elisabeth Müller-Holzner; Martin Widschwendter; Melanie Ehrlich
DNA hypomethylation is prevalent even in low-grade breast cancers.
Cancer biology & therapy 2004;3(12):1225-31.
2004: Hannes M Müller; Simone Millinger; Heidi Fiegl; Georg Goebel; Lennart Ivarsson; Andreas Widschwendter; Elisabeth Müller-Holzner; Christian Marth; Martin Widschwendter
Analysis of methylated genes in peritoneal fluids of ovarian cancer patients: a new prognostic tool.
Clinical chemistry 2004;50(11):2171-3.
2004: Martin Widschwendter; Guanchao Jiang; Christian Woods; Hannes M Müller; Heidi Fiegl; Georg Goebel; Christian Marth; Elisabeth Müller-Holzner; Alain G Zeimet; Peter W Laird; Melanie Ehrlich
DNA hypomethylation and ovarian cancer biology.
Cancer research 2004;64(13):4472-80.
2004: Hannes M Müller; Andreas Widschwendter; Heidi Fiegl; Georg Goebel; Annemarie Wiedemair; Elisabeth Müller-Holzner; Christian Marth; Martin Widschwendter
A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer.
Cancer letters 2004;209(2):231-6.
2004: Hannes M Müller; Heidi Fiegl; Andreas Widschwendter; Martin Widschwendter
Prognostic DNA methylation marker in serum of cancer patients.
Annals of the New York Academy of Sciences 2004;1022():44-9.
2004: Martin Widschwendter; Kimberly D Siegmund; Hannes M Müller; Heidi Fiegl; Christian Marth; Elisabeth Müller-Holzner; Peter A Jones; Peter W Laird
Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen.
Cancer research 2004;64(11):3807-13.
2004: Hannes M Müller; Lennart Ivarsson; Hans Schröcksnadel; Heidi Fiegl; Andreas Widschwendter; Georg Goebel; Susanne Kilga-Nogler; Horst Philadelphy; Wolfgang Gütter; Christian Marth; Martin Widschwendter
DNA methylation changes in sera of women in early pregnancy are similar to those in advanced breast cancer patients.
Clinical chemistry 2004;50(6):1065-8.
2004: Michael Hubalek; Andreas Widschwendter; Martin Erdel; Andreas Gschwendtner; Heidi Fiegl; Hannes M Müller; Georg Goebel; Elisabeth Mueller-Holzner; Christian Marth; Charles H. Spruck; Steven I Reed; Martin Widschwendter
Cyclin E dysregulation and chromosomal instability in endometrial cancer.
Oncogene 2004;23(23):4187-92.
2004: Andreas Widschwendter; Conny Gattringer; Lennart Ivarsson; Heidi Fiegl; Alois Schneitter; Angela Ramoni; Hannes M Müller; Annemarie Wiedemair; Susanne Jerabek; Elisabeth Müller-Holzner; Georg Goebel; Christian Marth; Martin Widschwendter
Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3396-400.
2004: Heidi Fiegl; Conny Gattringer; Andreas Widschwendter; Alois Schneitter; Angela Ramoni; Daniela Sarlay; Inge Gaugg; Georg Goebel; Hannes M Müller; Elisabeth Mueller-Holzner; Christian Marth; Martin Widschwendter
Methylated DNA collected by tampons--a new tool to detect endometrial cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(5):882-8.
2004: Andreas Widschwendter; Hannes M Müller; Michael Hubalek; Annemarie Wiedemair; Heidi Fiegl; Georg Goebel; Elisabeth Mueller-Holzner; Christian Marth; Martin Widschwendter
Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
Gynecologic oncology 2004;93(2):407-16.
2004: Hannes M Müller; Michael Oberwalder; Heidi Fiegl; Maria Morandell; Georg Goebel; Matthias Zitt; Markus Mühlthaler; Dietmar Ofner; Raimund Margreiter; Martin Widschwendter
Methylation changes in faecal DNA: a marker for colorectal cancer screening?
Lancet 2004;363(9417):1283-5.
2004: Andreas Widschwendter; Lennart Ivarsson; Anya Blassnig; Hannes M Müller; Heidi Fiegl; Annemarie Wiedemair; Elisabeth Müller-Holzner; Georg Goebel; Christian Marth; Martin Widschwendter
CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients.
International journal of cancer. Journal international du cancer 2004;109(2):163-6.
2004: Barbara Del Frari; Petra Pülzl; Thomas Schoeller; Martin Widschwendter; Gottfried Wechselberger
Pregnancy as a tissue expander in the correction of a scar deformity.
American journal of obstetrics and gynecology 2004;190(2):579-80.
2004: Susanna Ekholm-Reed; Charles H. Spruck; Olle Sangfelt; Frank van Drogen; Elisabeth Mueller-Holzner; Martin Widschwendter; Anders Zetterberg; Steven I Reed; Susanna Ekholm Reed
Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer.
Cancer research 2004;64(3):795-800.
2004: Andreas Widschwendter; Hannes M Müller; Heidi Fiegl; Lennart Ivarsson; Annemarie Wiedemair; Elisabeth Müller-Holzner; Georg Goebel; Christian Marth; Martin Widschwendter
DNA methylation in serum and tumors of cervical cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):565-71.
2003: Hannes M Müller; Heidi Fiegl; Georg Goebel; Michael Hubalek; Andreas Widschwendter; Elisabeth Müller-Holzner; Christian Marth; Martin Widschwendter
MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status.
British journal of cancer 2003;89(10):1934-9.
2003: Hannes M Müller; Andreas Widschwendter; Heidi Fiegl; Lennart Ivarsson; Georg Goebel; Elisabeth Perkmann; Christian Marth; Martin Widschwendter
DNA methylation in serum of breast cancer patients: an independent prognostic marker.
Cancer research 2003;63(22):7641-5.
2003: Hannes M Müller; Martin Widschwendter
Methylated DNA as a possible screening marker for neoplastic disease in several body fluids.
Expert review of molecular diagnostics 2003;3(4):443-58.
2002: Melanie Ehrlich; Guanchao Jiang; Emerich Fiala; Jeffrey S Dome; Mimi C Yu; Tiffany I Long; Byungwoo Youn; Ock Soon Sohn; Martin Widschwendter; Gail Tomlinson; Murali Chintagumpala; Martin Champagne; David Parham; Gangning Liang; Karim Malik; Peter W Laird
Hypomethylation and hypermethylation of DNA in Wilms tumors.
Oncogene 2002;21(43):6694-702.
2002: Charles H. Spruck; Heimo M Strohmaier; Olle Sangfelt; Hannes M Müller; Michael Hubalek; Elisabeth Müller-Holzner; Christian Marth; Martin Widschwendter; Steven I Reed
hCDC4 gene mutations in endometrial cancer.
Cancer research 2002;62(16):4535-9.
2002: Martin Widschwendter; Peter A Jones
DNA methylation and breast carcinogenesis.
Oncogene 2002;21(35):5462-82.
2002: Alain G Zeimet; Elisabeth Müller-Holzner; A Schuler; G Hartung; J Berger; M Hermann; Martin Widschwendter; J M Bergelson; Christian Marth
Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas.
Gene therapy 2002;9(16):1093-100.
2002: Martin Widschwendter; Peter A Jones
The potential prognostic, predictive, and therapeutic values of DNA methylation in cancer. Commentary re: J. Kwong et al., Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin. Cancer Res., 8: 131-137, 2002, and H-Z. Zou et al., Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin. Cancer Res., 8: 188-191, 2002.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(1):17-21.
2001: Helmut Weiss; Albert Amberger; Martin Widschwendter; Raimund Margreiter; Dietmar Ofner; Paul Dietl
Inhibition of store-operated calcium entry contributes to the anti-proliferative effect of non-steroidal anti-inflammatory drugs in human colon cancer cells.
International journal of cancer. Journal international du cancer 2001;92(6):877-82.
2001: Martin Widschwendter; J Berger; H M Müller; Alain G Zeimet; C Marth
Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer.
Journal of mammary gland biology and neoplasia 2001;6(2):193-201.
2000: Alain G Zeimet; Sylvia Stadlmann; Clara Natoli; Martin Widschwendter; M Hermann; Burkhardt Abendstein; Guenter Daxenbichler; Felix Offner; Stefano Iacobelli; Christian Marth
Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90K.
Anticancer research 2000;20(6B):4507-11.
2000: Alain G Zeimet; K Riha; J Berger; Martin Widschwendter; M Hermann; Guenter Daxenbichler; C Marth
New insights into p53 regulation and gene therapy for cancer.
Biochemical pharmacology 2000;60(8):1153-63.
2000: Anton Bergant; Martin Widschwendter; Norbert Sepp
Bilateral nipple ulcers in a breastfeeding woman: a manifestation of Behcet's disease?
BJOG : an international journal of obstetrics and gynaecology 2000;107(10):1320-2.
2000: Martin Widschwendter; J Berger; M Hermann; Hannes M Müller; Albert Amberger; M Zeschnigk; Andreas Widschwendter; Burkhardt Abendstein; Alain G Zeimet; Guenter Daxenbichler; Christian Marth
Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.
Journal of the National Cancer Institute 2000;92(10):826-32.
2000: Burkhardt Abendstein; Alain G Zeimet; M Rieger; Martin Widschwendter; Felix Offner; Elisabeth Müller-Holzner
Alveolar echinococcosis with bulky peritoneal spread--a rare but important diagnosis in gynaecological practice.
BJOG : an international journal of obstetrics and gynaecology 2000;107(5):695-7.
2000: J Berger; A Telser; Martin Widschwendter; Elisabeth Müller-Holzner; Guenter Daxenbichler; Christian Marth; Alain G Zeimet
Expression of retinoic acid receptors in non-neoplastic epithelial disorders of the vulva and normal vulvar skin.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2000;19(2):95-102.
2000: Burkhardt Abendstein; Christian Marth; Elisabeth Müller-Holzner; Martin Widschwendter; Guenter Daxenbichler; Alain G Zeimet
Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.
Cancer 2000;88(6):1432-7.
1999: Christian Murr; Anton Bergant; Martin Widschwendter; Kurt Heim; Hans Schröcksnadel; Dietmar Fuchs
Neopterin is an independent prognostic variable in females with breast cancer.
Clinical chemistry 1999;45(11):1998-2004.
1999: Martin Widschwendter; M Hermann; M Niescher; C Marth; A G Zeimet
Smoking in pregnancy.
Lancet 1999;354(9187):1390.
1999: Martin Widschwendter; Andreas Widschwendter; Thomas Welte; Guenter Daxenbichler; Alain G Zeimet; Anton Bergant; J Berger; Jean-Philippe Peyrat; S Michel; Wolfgang Doppler; Christian Marth
Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitro.
British journal of cancer 1999;79(2):204-10.
1998: Christian Marth; Alain G Zeimet; Martin Widschwendter; Guenter Daxenbichler
Regulation of CA 125 expression in cultured human carcinoma cells.
The International journal of biological markers 1998;13(4):207-9.
1998: Martin Widschwendter; Hans Schröcksnadel; Manfred G Mörtl
Pre-eclampsia: a disorder of placental mitochondria?
Molecular medicine today 1998;4(7):286-91.
1998: Bernhard Meister; Franz-Martin Fink; Anton Hittmair; Christian Marth; Martin Widschwendter
Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma.
Anticancer research 1998;18(3A):1777-86.
1998: Alain G Zeimet; Martin Widschwendter; C Knabbe; Dietmar Fuchs; Manfred Herold; Elisabeth Müller-Holzner; Guenter Daxenbichler; Felix Offner; Otto Dapunt; Christian Marth
Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1861-8.
1998: Hannes M Müller; Martin Widschwendter; Manfred G Mörtl; Hans Schröcksnadel
[Prediction of preeclampsia:new hypotheses, new approaches].
Gynäkologisch-geburtshilfliche Rundschau 1998;38(4):222-31.
1998: Alain G Zeimet; Felix Offner; Elisabeth Müller-Holzner; Martin Widschwendter; Burkhardt Abendstein; L C Fuith; Guenter Daxenbichler; Christian Marth
Peritoneum and tissues of the female reproductive tract as physiological sources of CA-125.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1998;19(4):275-82.
1997: Martin Widschwendter; J Berger; Guenter Daxenbichler; Elisabeth Müller-Holzner; Andreas Widschwendter; A Mayr; Christian Marth; Alain G Zeimet
Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer.
Cancer research 1997;57(19):4158-61.
1997: Christian Marth; Alain G Zeimet; Martin Widschwendter; C Ludescher; Janne Kaern; Claes Tropé; Guenther Gastl; Guenter Daxenbichler; Otto Dapunt
Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cells.
Cancer research 1997;57(17):3818-22.
1997: Martin Widschwendter; Guenter Daxenbichler; Zoran Culig; S Michel; Alain G Zeimet; Manfred G Mörtl; Andreas Widschwendter; Christian Marth
Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell lines.
International journal of cancer. Journal international du cancer 1997;71(3):497-504.
1997: Alain G Zeimet; Martin Widschwendter; M Uhl-Steidl; Elisabeth Müller-Holzner; Guenter Daxenbichler; Christian Marth; Otto Dapunt
High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer.
British journal of cancer 1997;76(12):1646-51.
1997: Christian Marth; Martin Widschwendter; Janne Kaern; N P Jørgensen; Gudrun Windbichler; Alain G Zeimet; Claes Tropé; Guenter Daxenbichler
Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells.
British journal of cancer 1997;76(10):1328-32.
1996: Gudrun Windbichler; E Hensler; Martin Widschwendter; A Posch; Guenter Daxenbichler; E Fritsch; Christian Marth
Increased radiosensitivity by a combination of 9-cis-retinoic acid and interferon-y in breast cancer cells.
Gynecologic oncology 1996;61(3):387-94.
1996: Guenter Daxenbichler; Martin Widschwendter; Christian Marth
Sensitivity of breast and ovarian cancer cells for interferons (IFNs) and retinoids.
Annals of the New York Academy of Sciences 1996;784():294-303.
1996: Alain G Zeimet; Christian Marth; D Fuchs; M Herold; Martin Widschwendter; Guenter Daxenbichler; S Iacobelli; Otto Dapunt
[Immunostimulating protein 90K in ovarian carcinoma].
Gynäkologisch-geburtshilfliche Rundschau 1996;36(1):44-5.
1996: Martin Widschwendter; Guenter Daxenbichler; F Bachmair; E Müller; Alain G Zeimet; Gudrun Windbichler; M Uhl-Steidl; T Lang; Christian Marth
Interaction of retinoic acid and interferon-alpha in breast cancer cell lines.
Anticancer research 1996;16(1):369-74.
1995: Christian Marth; T Lang; Martin Widschwendter; Elisabeth Müller-Holzner; Guenter Daxenbichler
Effects of Taxol on choriocarcinoma cells.
American journal of obstetrics and gynecology 1995;173(6):1835-42.
1995: Martin Widschwendter; Guenter Daxenbichler; Otto Dapunt; Christian Marth
Effects of retinoic acid and gamma-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells.
Cancer research 1995;55(10):2135-9.
1994: Christian Marth; A Dreps; C Natoli; Alain G Zeimet; T Lang; Martin Widschwendter; Guenter Daxenbichler; A Ullrich; S Iacobelli
Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cells.
International journal of cancer. Journal international du cancer 1994;59(6):808-13.
1994: Bernhard Meister; M Tötsch; A Mayr; Martin Widschwendter; O Huter; Wolfgang Sperl
Identification of CD34+ cord blood cells and their subpopulations in preterm and term neonates using three-color flow cytometry.
Biology of the neonate 1994;66(5):272-9.
1993: Christian Marth; Martin Widschwendter; Guenter Daxenbichler
Mechanism of synergistic action of all-trans- or 9-cis-retinoic acid and interferons in breast cancer cells.
The Journal of steroid biochemistry and molecular biology 1993;47(1-6):123-6.
1993: Bernhard Meister; M Herold; A Mayr; Martin Widschwendter; H Maurer; Kurt Heim; Wolfgang Sperl
Interleukin-3, interleukin-6, granulocyte-macrophage colony-stimulating factor and erythropoietin cord blood levels of preterm and term neonates.
European journal of pediatrics 1993;152(7):569-73.